Author

Douglas J. DiGirolamo

Observed names: D.J. DiGirolamo, DiGirolamo, Douglas J, Douglas DiGirolamo, Douglas J DiGirolamo, Douglas J Digirolamo, Douglas J. Digirolamo

Observed institutions: Pennsylvania State University, Johns Hopkins University, National Foundation for Cancer Research, Johns Hopkins Medicine, University of Alabama at Birmingham, UAB Medicine

OpenAlex ID: A5016202341

Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition

2010 · Keertik Fulzele, Ryan C. Riddle, et al. · Cell · 771

PDF

Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism

2009 · Yong Fan, Ram K. Menon, et al. · Journal of Biological Chemistry · 255

PDF

Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice

2010 · Mahendra D. Mavalli, Douglas J. DiGirolamo, et al. · Journal of Clinical Investigation · 213

PDF

Bone and Skeletal Muscle: Neighbors With Close Ties

2013 · Douglas J DiGirolamo, Douglas P Kiel, et al. · Journal of Bone and Mineral Research · 193

The skeleton as an endocrine organ

2012 · Douglas J. DiGirolamo, Thomas L. Clemens, et al. · Nature Reviews Rheumatology · 178

Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action

2007 · Keertik Fulzele, Douglas J. DiGirolamo, et al. · Journal of Biological Chemistry · 145

Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone?

2014 · Christian M. Girgis, Nancy Mokbel, et al. · Current Osteoporosis Reports · 110

Mode of Growth Hormone Action in Osteoblasts

2007 · Douglas J. DiGirolamo, Aditi Mukherjee, et al. · Journal of Biological Chemistry · 102

Breast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation

2003 · Andrea M. Mastro, Carol V. Gay, et al. · Journal of Cellular Biochemistry · 86

Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass

2017 · Brian C. Goh, Vandana Singhal, et al. · Journal of Biological Chemistry · 63

PDF

Tsc2 Is a Molecular Checkpoint Controlling Osteoblast Development and Glucose Homeostasis

2014 · Ryan C. Riddle, Julie L. Frey, et al. · Molecular and Cellular Biology · 57

Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta

2015 · Douglas J. DiGirolamo, Vandana Singhal, et al. · Bone Research · 56

PDF

Nrf2 is required for normal postnatal bone acquisition in mice

2014 · Jung-Hyun Kim, Vandana Singhal, et al. · Bone Research · 53

PDF

Biophysical cues enhance myogenesis of human adipose derived stem/stromal cells

2013 · P. Yilgor Huri, C.A. Cook, et al. · Biochemical and Biophysical Research Communications · 51

Biophysical Stimulation for Engineering Functional Skeletal Muscle

2017 · Sarah M. Somers, Alexander A. Spector, et al. · Tissue Engineering Part B Reviews · 42

Deletion of IGF-I Receptor (IGF-IR) in Primary Osteoblasts Reduces GH-Induced STAT5 Signaling

2010 · Yujun Gan, Yue Zhang, et al. · Molecular Endocrinology · 30

Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition

2022 · Keertik Fulzele, Ryan C. Riddle, et al. · Cell · 28

PDF

Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment

2005 · Monica M Richert, Pushkar A Phadke, et al. · Breast Cancer Research · 25

PDF

Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes

2013 · Vandana Singhal, Brian C. Goh, et al. · Bone Research · 17

PDF

Growth and Growth Hormone Use in Osteogenesis Imperfecta

2013 · Emily L. Germain-Lee, Douglas J. DiGirolamo, et al. · Elsevier eBooks · 2

Effects of aging on bone

2014 · Douglas J. Digirolamo, Emily L. Germain-Lee · Elsevier eBooks · 1

Contributors

2014 · Martha Acosta, Cheryl L. Anderson, et al. · Elsevier eBooks

List of Contributors

2013 · Mona Aglan, Yasemin Alanay, et al. · Elsevier eBooks

Α-Difluoromethylornithine (DFMO) decreases the incidence and size of bone metastases from MDA-MB-43

2011 · Monica M. Richert Welch, Pushkar Phadke, et al.

Α-difluoromethylornithine (DFMO) treatment decreases meprin α expression in MDA-MB-435 cells, but

2011 · Monica M. Richert Welch, Pushkar Phadke, et al.

Works count: 32

Citation count: 2,478

H-index: 18

I10-index: 19